TORNTPHARM.NSTORNTPHARM.NS
LOADING
|||
EBITDA Over Time
Trending higher, above historical average, modest growth trend.
Left:
||||
Earnings before interest, taxes, depreciation, and amortization
Latest
$36.76B
↑ 52% above average
Average (9y)
$24.18B
Historical baseline
Range
High:$36.76B
Low:$13.44B
CAGR
+3.2%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2025 | $36.76B | +10.6% |
| 2024 | $33.25B | +18.6% |
| 2023 | $28.03B | +17.6% |
| 2022 | $23.82B | -1.9% |
| 2021 | $24.29B | +14.7% |
| 2020 | $21.18B | +8.0% |
| 2019 | $19.61B | +45.9% |
| 2018 | $13.44B | -2.4% |
| 2017 | $13.77B | -50.2% |
| 2016 | $27.65B | - |